Still, significant enrichments of altered pathway genes were observed for MAPK, PI3K-Akt and VEGF signaling and cytokine receptor interactions in dependency of the specific comparison of two CML phases. This evidence concerns the gene VEGFA and chronic myelogenous leukemia, BCR-ABL1 positive.